{"nct_id":"NCT02365649","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2015-03-17","start_date_type":"ACTUAL","primary_completion_date":"2016-11-25","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}